Marc Shepard Built NECANN for the Locals. Now the Fight Comes Home

The NECANN Model: Hyperlocal Expos in a Fragmented Regulatory Landscape

Shepard launched NECANN in 2014 as a state-by-state conference series designed to navigate the Northeast's patchwork of cannabis laws, long before adult-use legalization reached the region. Unlike national expos that aggregate thousands of exhibitors under one roof, NECANN runs smaller shows—typically 150-300 booths—in individual states: Massachusetts, Vermont, New Jersey, Connecticut, and Rhode Island. Each event caters to that state's specific licensing structure, cultivation climate, and consumer base.

The format reflects the Northeast's regulatory reality. No two states share identical rules:

• Massachusetts caps cultivation licenses by municipality and allows social-equity applicants priority windows
• Vermont restricts vertical integration and bans out-of-state ownership until 2027
• New Jersey operates a conditional-license lottery with residency requirements
• Connecticut awards points for in-state operating history and local hiring commitments

Shepard's pitch: if you're growing in Vermont's clay-heavy soil or navigating New Jersey's municipal opt-in wars, you don't need a keynote from a Colorado MSO. You need the grower two towns over. The one who cracked the same problem last season.

Consolidation Pressure: Out-of-State Capital Floods Regional Markets

The threat Shepard describes isn't hypothetical—Northeast cannabis markets saw $1.8 billion in M&A activity in 2025, with multi-state operators acquiring 47% of independent Massachusetts dispensaries and 31% of New Jersey cultivation facilities, according to industry tracker MJBizDaily. Curaleaf, Verano, and Acreage Holdings now control more than half of the region's retail footprint, a concentration that didn't exist three years ago when state-residency caps and local-ownership incentives were still enforceable.

Vermont's 2027 sunset on out-of-state ownership bans has accelerated the land grab. Shepard points to a single county—Chittenden, home to Burlington—where four of seven licensed cultivators sold majority stakes to Illinois- or Florida-based holding companies in the past 18 months. The new owners kept the Vermont branding but replaced head growers, switched to cookie-cutter strain menus (Wedding Cake, Gelato, Zkittlez), and rerouted flower to higher-margin Massachusetts dispensaries.

The fight Shepard started NECANN to wage—keeping Northeast cannabis weird, local, and resistant to coast-to-coast homogenization—has circled back as the region's last state-residency protections expire and capital markets reward scale over terroir.

It's a pattern visible across the region. Connecticut's first adult-use harvest in early 2026 saw three of the state's top five cultivators (by square footage) flip to MSO ownership before a single gram reached retail. The buyers: Trulieve, Cresco, and a SPAC-backed roll-up that also owns dispensaries in Ohio and Pennsylvania.

What the Northeast Loses When Local Growers Sell

Shepard's argument isn't nostalgia—it's operational. Northeast growers adapted cultivars to short seasons, high humidity, and finicky consumers who want variety over THC-percentage arms races. Strains like Lemon Skunk (a Massachusetts staple since the medical era), Northern Lights cuts preserved by Vermont legacy growers, and Sour Diesel phenos specific to New Jersey's coastal climate don't appear on MSO menus, which prioritize strains that travel well, test high, and play in every market from Arizona to Illinois.

When a Vermont cultivator sells to an MSO, the new operator typically:

• Replaces proprietary genetics with corporate clone libraries (usually California-bred hybrids optimized for yield, not flavor)
• Switches to hydroponic systems that eliminate terroir but standardize output across facilities in six states
• Fires tenured growers (average regional salary: $58K) and hires cheaper labor managed remotely by out-of-state cultivation directors
• Reroutes flower to the MSO's highest-margin retail markets, leaving the local state underserved during peak demand (a dynamic visible in Massachusetts in Q4 2025, when three formerly independent cultivators stopped supplying in-state dispensaries to fulfill Curaleaf's New Jersey wholesale contracts)

The result, Shepard says, is a flattening of regional identity. Walk into a Curaleaf in Burlington or a Verano in Montclair, and the strain menu, the packaging, the price points, and the customer experience are nearly identical. The lemon-pith finish of a Massachusetts Lemon Skunk? Gone. The forest-floor opener of a Vermont Northern Lights? Replaced by a Gelato that could've been grown anywhere.

For background on how regional cannabis markets are navigating MSO consolidation, see the CannIntel topic hub on NECANN and Northeast cannabis.